Ari V. Kazanjian

Ari V. Kazanjian has extensive work experience in the biotechnology and pharmaceutical industries. They are currently a Principal Engineer at Arranta Bio, where they began in November 2022. Prior to this role, Ari was a Senior Engineer at Arranta Bio from February 2022 to October 2022.

Before joining Arranta Bio, Ari worked at Pfizer as a Process Scientist/Engineer III from September 2020 to February 2022. They also held the position of Associate Scientist/Engineer from February 2019 to August 2020 at Pfizer. Ari began their career at Pfizer as a Rotational Development Program Associate from July 2017 to February 2019.

Ari's earlier experiences include working at MilliporeSigma as Operational Excellence from June 2016 to September 2016, and as Research and Development for Process Solutions from May 2015 to September 2015. They also served as a Research Assistant at Tufts University from May 2013 to August 2013.

Overall, Ari V. Kazanjian has held various positions, demonstrating their expertise and contributions in the biotechnology and pharmaceutical sectors, with a strong focus on process development and excellence.

Ari V. Kazanjian has a Bachelor's Degree in Chemical and Biological Engineering from Tufts University, which was completed from 2013 to 2017. Additionally, they obtained a Certificate in Advanced Management from Babson F.W. Olin Graduate School of Business, which was completed between 2017 and 2018.